PT Pyridam Farma Tbk

Jakarta Stock Exchange PYFA.JK

PT Pyridam Farma Tbk EBT Margin for the year ending December 31, 2023: -11.86%

PT Pyridam Farma Tbk EBT Margin is -11.86% for the year ending December 31, 2023, a -132.25% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • PT Pyridam Farma Tbk EBT Margin for the year ending December 31, 2022 was 36.77%, a 2,531.41% change year over year.
  • PT Pyridam Farma Tbk EBT Margin for the year ending December 31, 2021 was 1.40%, a -86.92% change year over year.
  • PT Pyridam Farma Tbk EBT Margin for the year ending December 31, 2020 was 10.69%, a 110.93% change year over year.
  • PT Pyridam Farma Tbk EBT Margin for the year ending December 31, 2019 was 5.07%, a 12.11% change year over year.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
Loading...
SV Wall Street
Jakarta Stock Exchange: PYFA.JK

PT Pyridam Farma Tbk

CEO Mr. Yan Gwan Lee
IPO Date Oct. 16, 2001
Location Indonesia
Headquarters Sinarmas MSIG Tower
Employees 1,193
Sector Health Care
Industries
Description

PT Pyridam Farma Tbk develops, produces, and sells pharmaceuticals, antibiotics, vitamins, supplements, and traditional herbal care products in Indonesia. The company operates in two segments, Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. It offers medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR – extraction kit and extractor machine, speciment bag, sterile container, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; products in the areas of alimentary t. and metabolism, blood and blood forming organs, cardiovascular system, dermatologicals, G.U. system and sex hormones, systemic corticosteroids, systemic antibacterial, sensory organs, as well as musculo-skeletal, nervous, and respiratory systems; and supplements and other preventive consumer health products with energy drinks and healthy ready-to-drink products. In addition, it engages in the research and development on biotechnology, life, and medical science. The company was founded in 1976 and is headquartered in Jakarta, Indonesia.

Similar companies

MERK.JK

PT Merck Tbk

USD 0.22

1.06%

KAEF.JK

PT Kimia Farma (Persero) Tbk

USD 0.04

-0.01%

MRAT.JK

PT Mustika Ratu Tbk

USD 0.02

1.64%

TSPC.JK

PT Tempo Scan Pacific Tbk

USD 0.15

2.05%

StockViz Staff

January 31, 2025

Any question? Send us an email